Pei-Yen Yeh

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-κB (NF-κB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells

Shuang‐En Chuang, Pei-Yen Yeh, Yen‐Shen Lu et al. · Biochemical Pharmacology · 2002 · 157 citations

Anticancer Drug-induced Activation, Oncology, Chemoprevention Strategy +11

Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway

Kuen‐Feng Chen, Pei-Yen Yeh, Chiun Hsu et al. · Journal of Biological Chemistry · 2009 · 82 citations · Full text

Phosphatidylinositol 3-Kinase/akt, Cell Signaling, Medicine +15

Nuclear Expression of BCL10 or Nuclear Factor Kappa B Predicts <i>Helicobacter pylori</i>–Independent Status of Early-Stage, High-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphomas

Sung‐Hsin Kuo, Li‐Tzong Chen, Kun‐Huei Yeh et al. · Journal of Clinical Oncology · 2004 · 56 citations · Full text

Overexpression of B cell–activating factor of TNF family (BAFF) is associated with Helicobacter pylori–independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma

Sung‐Hsin Kuo, Pei-Yen Yeh, Li‐Tzong Chen et al. · Blood · 2008 · 53 citations · Full text

The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma

Zhong-Zhe Lin, Hey-Chi Hsu, Chih‐Hung Hsu et al. · Journal of Hepatology · 2008 · 45 citations

Human Hepatocellular Carcinoma, Medicine, Pre-clinical Studies +7